The Next Four Years Could Be Huge For US CBD Companies - Seite 2

HempFusion's wholly-owned subsidiary Probulin Probiotics LLC is a successful probiotics company and is pivotal in deploying the company's 'Trojan Horse' strategy as a gateway to gain access to new markets as US regulatory development accelerates over the next four years. HempFusion's Probulin subsidiary is a market-leading probiotics brand that does not include CBD products. HempFusion's Probulin, already successful and one of the fastest growing probiotic companies in the Natural products market, according to SPIN data, may allow the company to enter markets and retailers before they open up to CBD. As regulations develop, HempFusion is able to use those established relationships and trust to make sure its products are among the first stocked.

The Nation's Largest CBD Producers See Renewed Opportunity

Around the industry, hemp-CBD and cannabis producers are looking at Biden's victory as a source of new optimism for cannabis companies. Tilray Inc (NASDAQ:TLRY) has been one of the cannabis industry's top performers so far in 2021 since the cannabis giant merged with Aphria to become the largest company in the industry.

Canopy Growth Corp (NASDAQ:CGC) (TSX:WEED) also celebrated the results of the election. The Canadian company has been looking south to the US market for some time now, and the regulatory headwind that cannabis companies expect from the Biden administration will likely remove barriers to US expansion.

That regulatory headwind would likely also be a boon to Cronos Group Inc (NASDAQ:CRON) (TSX:CRON). Cronos announced in 2019 that the company would be expanding into the US market through the acquisition of four hemp-derived CBD subsidiaries from US-based Redwood Holding Group.

OrganiGram Holdings Inc (TSX:OGI) (NASDAQ:OGI) released its first quarter 2021 results on January 12, recording extremely positive results. For adult-use recreational products, the company saw gross and net revenue growth of 42 percent and 30 percent, respectively, reaching $22.5 million and $16.8 million.

The next four years could be big days for the United States hemp-CBD and cannabis markets, and companies are looking to take advantage of the growth opportunity. For HempFusion Wellness, this means using the company's uncompromising approach to compliance to gain access to new markets early as they open up.